Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Sunesis Pharmaceuticals Inc
Sunesis Pharmaceuticals Inc_20100128
  

Sunesis Pharmaceuticals Inc patents

Recent patent applications related to Sunesis Pharmaceuticals Inc. Sunesis Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Sunesis Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Sunesis Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "S" | Sunesis Pharmaceuticals Inc-related inventors




Date Sunesis Pharmaceuticals Inc patents (updated weekly) - BOOKMARK this page
08/10/17Stable sns-595 compositions and methods of preparation
06/29/17Methods of using sns-595 for treatment of cancer subjects with reduced brca2 activity
06/08/17Compounds useful as raf kinase inhibitors
05/04/17Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of certain hematologic disorders
04/27/17Inhibitors of bruton's tyrosine kinase
04/13/17Compounds and compositions for treatment of cancer
02/09/17Method of preparing (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
02/02/17Heterocyclic tyrosine kinase inhibitors
12/29/16Bruton's tyrosine kinase inhibitors
12/15/16Sns-595 and methods of using the same
11/17/16Heterocyclic compounds useful as pdk1 inhibitors
11/03/16Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid in combination therapy
11/03/16Biaryl bruton's tyrosine kinase inhibitors
10/27/16Biaryl inhibitors of bruton's tyrosine kinase
10/20/16Pyrimidinyl tyrosine kinase inhibitors
09/10/15Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of antecedent hematologic disorders
07/23/15Methods of using sns-595 for treatment of cancer subjects with reduced brca2 activity
07/09/15Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of certain hematologic disorders
07/09/15Sns-595 and methods of using the same
06/11/15Method of preparing (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
06/11/15Pyrimidinyl tyrosine kinase inhibitors
06/04/15Compounds and compositions for treatment of cancer
05/07/15Inhibitors of bruton's tyrosine kinase
03/19/15Compounds useful as raf kinase inhibitors
01/15/15Pyridinonyl pdk1 inhibitors
12/25/14Sns-595 and methods of using the same
09/18/14Stable sns-595 compositions and methods of preparation
07/24/14Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid in combination therapy
07/24/14Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer
06/19/14Method of preparing (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
09/19/13Sns-595 and methods of using the same
04/25/13Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of antecedent hematologic disorders
09/27/12Compounds and compositions for treatment of cancer
03/29/12Novel ligands and libraries of ligands
12/22/11Sns-595 and methods of using the same
12/01/11Aurora kinase inhibitors
10/27/11Sns-595 and methods of using the same
05/19/11Methods of chemotype evolution
01/13/11Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of antecedent hematologic disorders
11/25/10Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
07/15/10Thienopyrimidines useful as aurora kinase inhibitors
02/04/10Compounds and compositions for treatment of cancer
01/28/10Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules
02/05/09Compounds useful as raf kinase inhibitors
01/28/10Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Sunesis Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Sunesis Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';